Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThames V.2 Dp67 Regulatory News (D467)

  • This share is currently suspended. It was suspended at a price of 24.00
  • There is currently no data for D467

Net Asset Values and Portfolio Updates

3 Aug 2021 18:49

Net Asset Values and Portfolio Updates

Downing FOUR VCT plc (the “Company”)LEI: 21380035MV1VRYEXPR95 Net Asset Values and Portfolio Updates3 August 2021

The Company announces that the unaudited Net Asset Values (“NAVs”) of its Share Classes, as at 31 July 2021, were as follows:

 Unaudited
 31 July 2021
 Pence
Generalist Share pool 
Net Asset Value (“NAV”) per Generalist Share66.5
Cumulative distributions2.5
Total Return per Generalist Share69.0
  
Healthcare Share pool 
Net Asset Value (“NAV”) per Healthcare Share81.5
Cumulative distributions2.5
Total Return per Healthcare Share84.0
  
DSO D Share pool 
Net Asset Value (“NAV”) per DSO D Share10.0
Cumulative distributions94.5
Adjusted for Performance Incentive estimate(0.4)
Total Return per DSO D Share104.1
  
DP67 Share pool 
Net Asset Value (“NAV”) per DP67 Share19.5
Cumulative distributions (since original launch)67.8
Total Return per DP67 Share87.3

The unaudited Balance Sheet of the Company is shown below, followed by a summary of the portfolio of investments held by each Share Class.

UNAUDITED BALANCE SHEET as at 31 July 2021

 Unaudited31 July 2021  Audited31 March 2021
 £’000 £’000
Fixed assets    
Investments 44,016 40,743
Current assets    
Debtors 406 701
Cash at bank and in hand 6,970 6,986
  7,376 7,687
Creditors: amounts falling due within one year (457) (381)
Net current assets6,919 7,306
Net assets 50,935 48,049
     
Capital and reserves    
Called up Share capital  102 102
Other reserves 58 58
Special reserve 29,111 29,417
Share premium account 20,493 20,010
Funds held in respect of shares not yet allotted 346 241
Revaluation reserve 1,681 (1,143)
Capital reserve – realised 3,165 3,132
Revenue reserve (4,021) (3,768)
Total equity Shareholders’ funds 50,935 48,049
    

PORTFOLIO SUMMARIES

as at 31 July 2021

Generalist Share Pool Cost Valuation% ofnet assets
Portfolio of investments (unaudited) £’000  £’000  
Venture Capital investments   
E-Fundamentals (Group) Limited 1,342  2,760 8.64%
Imagen Limited 1,000  2,020 6.33%
Virtual Class Limited (Third Space Learning) 1,053  1,833 5.74%
Rated People Limited 1,282  1,583 4.95%
Cornelis Networks, Inc. 1,402  1,294 4.05%
Streethub Limited (t/a Trouva) 1,208  1,273 3.98%
Firefly Learning Limited 1,047  1,047 3.28%
Ecstase Limited (t/a ADAY) 1,000  1,000 3.13%
Trinny London Limited 219  957 2.99%
Limitless Technology Limited 757  920 2.88%
FundingXchange Limited 1,050  786 2.46%
Hackajob Limited 784  784 2.45%
Congenica Limited 734  746 2.33%
Arecor Therapeutics plc^^ 418  743 2.32%
Ayar Labs, Inc. 764  720 2.25%
Parsable, Inc. 766  672 2.10%
Masters of Pie Limited 667  667 2.09%
Carbice Corporation 656  603 1.89%
Hummingbird Technologies Limited 750  535 1.67%
JRNI Limited 525  525 1.64%
Maverick Pubs (Holdings) Limited 1,000  450 1.41%
Fenkle Street LLP 301  388 1.21%
Cambridge Touch Technologies Limited 459  361 1.13%
Exonar Limited 550  358 1.12%
Destiny Pharma plc^^ 500  354 1.11%
Xupes Limited 933  291 0.91%
Channel Mum Limited 675  278 0.87%
Empiribox Holdings Limited 1,563  262 0.82%
FVRVS Limited (t/a Fundamental VR) 250  250 0.78%
Upp Technologies Group Limited (prev. Volo Commerce) 1,077  242 0.76%
Lineten Limited 400  209 0.65%
MIP Diagnostics Limited 200  200 0.63%
Lignia Wood Company Limited 1,778  - 0.00%
Live Better With Limited 1,211  - 0.00%
Ormsborough Limited 900  - 0.00%
Glownet Limited 741  - 0.00%
 29,962 25,111 78.57%
Liquidity investments   
Downing Strategic Micro-Cap Investment Trust plc^ 4,269  3,050 9.54%
MI Downing UK Micro-Cap Growth Fund 124  99 0.31%
  4,393  3,149 9.85%
 34,35528,26088.42%
Cash at bank and in hand 3,77311.80%
Other current assets (71)(0.22%)
Net assets  31,962 100.0%

^ listed and traded on the London Stock Exchange^^ listed and traded on AIM

Healthcare Share Pool  Cost Valuation% ofnet assets
Portfolio of investments (unaudited) £’000  £’000  
Venture Capital investments   
Arecor Therapeutics plc^^ 1,533  2,726 17.04%
GENinCode plc^^ 1,202  2,165 13.53%
Adaptix Limited 1,056  1,381 8.63%
Open Bionics Limited 1,000  1,379 8.61%
Congenica Limited 1,184  1,215 7.59%
Future Health Works Limited (t/a MyRecovery)  528  556 3.48%
The Electrospinning Company Limited 478  544 3.40%
Destiny Pharma plc^^ 750  530 3.31%
FVRVS Limited (t/a Fundamental VR) 500  500 3.13%
Invizius Limited 500  500 3.13%
DiA Imaging Analysis Limited 415  405 2.53%
Cambridge Respiratory Innovations Limited 400  400 2.50%
MIP Diagnostics Limited 200  200 1.25%
Live Better With Limited 1,106 -0.00%
 10,85212,501 78.13%
Liquidity Investments   
Downing Strategic Micro-Cap Investment Trust plc^ 729  520 3.25%
MI Downing UK Micro-Cap Growth Fund 40  32 0.20%
  769  552 3.45%
 11,62113,05381.58%
Cash at bank and in hand 2,87217.95%
Other current assets 750.47%
Net assets  16,000100.0%

^ listed and traded on the London Stock Exchange^^ listed and traded on AIM

DSO D Share pool CostValuation% ofnet assets
Portfolio of investments (unaudited) £’000  £’000  
Venture Capital investments   
Fresh Green Power Limited 189  279 35.36%
Pearce and Saunders Limited 275  76 9.63%
Green Energy Production UK Limited 100  66 8.37%
Pearce and Saunders DevCo Limited 19  19 2.41%
  583  440 55.77%
Cash at bank and in hand  315 39.92%
Other current assets  34 4.31%
Net assets  789100.00%

DP67 Share pool CostValuation% ofnet assets
Portfolio of investments (unaudited) £’000  £’000  
Venture Capital investments   
Cadbury House Holdings Limited 1,409  791 36.22%
Gatewales Limited 343  745 34.11%
Fenkle Street LLP 405  727 33.29%
Yamuna Renewables Limited 400  - 0.00%
London City Shopping Centre Limited 99  - 0.00%
  2,656  2,263 103.62%
Cash at bank and in hand 10 0.46%
Other current assets (89)(4.08%)
Net assets  2,184100.00%

Date   Source Headline
15th Nov 20244:05 pmGNWResults of General Meeting, Merger and Share Redesignation
15th Nov 20241:38 pmGNWNet Asset Value(s)
15th Nov 20247:00 amGNWSuspension of Listing
8th Nov 20245:00 pmGNWResult of General Meeting
11th Oct 20243:02 pmGNWProposed Merger and Offer
25th Sep 202412:21 pmGNWNet Asset Values
24th Sep 20244:40 pmGNWResults of AGM
24th Sep 20242:49 pmGNWInvestment Management Update
7th Aug 20244:30 pmGNWCorrection - Annual Financial Report
31st Jul 20243:40 pmGNWAnnual Financial Report
26th Jul 20244:32 pmGNWAnnouncement re: DISCUSSIONS REGARDING POSSIBLE COMBINATION OF THAMES VENTURES VCT 1 PLC AND THAMES VENTURES VCT 2 PLC
17th Jul 20249:21 amGNWPDMR Notification
28th Mar 20241:15 pmGNWCancellation of Listing of DSO D Shares and Cessation of Trading
15th Mar 202410:21 amGNWNet Asset Value(s)
29th Feb 20244:58 pmGNWDividend Declaration
21st Dec 20233:34 pmGNWHalf Yearly Results
18th Oct 20234:33 pmGNWSpecial administration of the Company’s custodian of quoted assets
13th Sep 20235:14 pmGNWNet Asset Values
13th Sep 20235:06 pmGNWCompany Secretary Change
13th Sep 20235:03 pmGNWResult of AGM
31st Jul 20233:57 pmGNWClosure of Offers for Subscription
31st Jul 20233:14 pmGNWFinal Results
31st May 20235:28 pmGNWTotal Voting Rights
30th May 20232:12 pmGNWOffer for Subscription Extension
12th May 20231:42 pmGNWIssue of Equity
2nd May 202310:49 amGNWTotal Voting Rights
5th Apr 20236:24 pmGNWIssue of Equity
31st Mar 20236:04 pmGNWTotal Voting Rights
31st Mar 20235:44 pmGNWTransaction in Own Shares
22nd Mar 20234:14 pmGNWNet Asset Values
31st Jan 20235:45 pmGNWTotal Voting Rights
17th Jan 20234:57 pmGNWTransaction in Own Shares & Total Voting Rights
22nd Dec 20225:08 pmGNWHalf-year report
13th Oct 20225:35 pmGNWPublication of Healthcare Prospectus
12th Oct 20224:40 pmGNWPortfolio Update and Net Asset Values
30th Sep 20225:27 pmGNWTotal Voting Rights
30th Sep 20225:25 pmGNWTransaction in Own Shares
28th Sep 20223:19 pmGNWDirectorate change
27th Sep 20225:56 pmGNWResult of AGM
7th Sep 202212:00 pmGNWChange of Name
1st Sep 202210:05 amGNWTotal Voting Rights
31st Aug 20224:59 pmGNWShare forfeiture and cancellation
3rd Aug 20225:12 pmGNWTransaction in Own Shares and Total Voting Rights
26th Jul 20227:00 amGNWNet Asset Value(s)
25th Jul 20226:28 pmGNWFinal Results
5th Jul 20227:00 amGNWCompletion of Sale of Downing non-healthcare ventures business to Foresight Group and Novation of Investment Management Agreement
30th Jun 20226:30 pmGNWTotal Voting Rights
13th Jun 20227:04 amGNWNovation of Investment Management Agreement
6th Jun 20224:34 pmGNWIssue of Equity
3rd May 202210:38 amGNWTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.